Altre lingue Notable Labs, Ltd.

Azioni

NTBL

IL0012002452

Prezzo di chiusura Nasdaq Altri mercati azionari 00:00:00 03/05/2024			Variaz. 5gg	Var. 1 gen.
0,95 ^USD	0,00%		-1,55%	-49,74%

15/04	NOTABLE LABS, LTD. : Chardan Research rimane Buy	ZM
15/04	NOTABLE LABS, LTD. : Chardan Research ribadisce il giudizio positivo sul titolo	ZM

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Notable Labs Reports 2023 Financial Results and Provides a Business Update	15/04
Notable Labs Reports 2023 Financial Results and Provides a Business Update	12/04
VASR BIOG : AACR 2024 VOLA Poster	09/04
Notable Labs Presents the Design Plan for the PPMP-Enabled Phase 2 Trial with Volasertib for Relapsed/Refractory AML at AACR 2024	09/04
Notable Labs, Ltd. Presents the Design Plan for the Ppmp-Enabled Phase 2 Trial with Volasertib for Relapsed/Refractory AML at AACR 2024	09/04
VASR BIOG : AACR 2024 Poster	08/04
Notable Labs Presentation of Data Related to Innovations in the Use of Cryopreserved Samples in the PPMP Assay at AACR 2024 Expands the Potential of the Platform	08/04
Notable Labs Presentation of Data Related to Innovations in the Use of Cryopreserved Samples in the PPMP Assay At AACR 2024 Expands the Potential of the Platform	08/04
OPINIONES DE LOS ANALISTAS DEL DÍA : Stellantis, Aena, Richemont, Adyen, Fraport, BBVA, Aperam, Enagás, Sacyr, BE Semi...	02/04
Notable Labs to Present Two Posters at AACR 2024 on PPMP Platform	05/03
Notable Advances Volasertib Phase 2 Program Utilizing Proprietary Predictive Precision Medicine Platform-Guided Enrollment	22/02
Notable Labs, Ltd. Advances Volasertib Phase 2 Program Utilizing Proprietary Predictive Precision Medicine Platform-Guided Enrollment	22/02
Top Premarket Gainers	09/01
Notable Reports Predictive Precision Medicine Platform (PPMP) Accurately Predicted Fosciclopirox Trial Outcome	18/12
Notable Labs, Ltd. and CicloMed LLC Announces Initial Safety and Efficacy Data of Fosciclopirox and the Performance of PPMP	18/12
Notable Labs to Participate in JMP Securities Hematology and Oncology Summit	04/12
Notable Labs Announces Filing of Form 10-Q for Third Quarter 2023	14/11
Notable Labs Announces JCO Precision Oncology Publication Demonstrating PPMP Potential to Identify Novel Drug Combinations in JMML	09/11
VASR BIOG : Letter from the CEO...	09/11
Vascular Biogenics, Notable Labs Complete Merger	16/10/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Notable Labs, Ltd.

Azioni

NTBL

IL0012002452

Altre lingue

Filtri